Skip to main content
News Directory 3
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
HPV Screening with Self Collection Endorsed by Two Organizations - News Directory 3

HPV Screening with Self Collection Endorsed by Two Organizations

January 19, 2026 Jennifer Chen Health
News Context
At a glance
  • The American Cancer Society (ACS) released updated cervical cancer screening guidelines at the end of 2025, and the Health Resources and Services Administration (HRSA) endorsed them in January...
  • both the ACS and HRSA agree on several core principles for cervical cancer screening.
  • Despite broad agreement, the ACS and HRSA guidelines diverge on certain aspects of screening frequency and duration.
Original source: ashasexualhealth.org

New Cervical Cancer Screening Guidelines Released

Table of Contents

  • New Cervical Cancer Screening Guidelines Released
  • Areas of Agreement Between ACS and HRSA Guidelines
  • Differences in Screening Recommendations
  • Resources

The American Cancer Society (ACS) released updated cervical cancer screening guidelines at the end of 2025, and the Health Resources and Services Administration (HRSA) endorsed them in January 2026. While largely consistent, the two sets of recommendations have some key distinctions.

Areas of Agreement Between ACS and HRSA Guidelines

both the ACS and HRSA agree on several core principles for cervical cancer screening.

  • HPV Primary Testing is Preferred. Both organizations recommend the HPV primary test for individuals aged 30-65 at average risk. This test identifies high-risk HPV types responsible for approximately 70% of cervical cancers. If the HPV primary test isn’t available, co-testing-an HPV test combined with a Pap test-is recommended. If co-testing isn’t available, a Pap test alone is acceptable.
  • Self-Collection is acceptable. Traditionally, healthcare providers collected samples for HPV and Pap tests during a speculum exam. The ACS prefers provider collection, but acknowledges self-collection as a valid option.

Differences in Screening Recommendations

Despite broad agreement, the ACS and HRSA guidelines diverge on certain aspects of screening frequency and duration.

  • Screening Intervals. The ACS recommends screening every five years with an HPV primary test, or every three years with a co-test. HRSA recommends screening every three to five years with a primary HPV test.
  • Age to Stop Screening. The ACS states that individuals 65 and older who have had adequate prior screening can stop. HRSA recommends that individuals 65 and older who have been adequately screened and do not have a history of serious cervical precancer can also stop.

Resources

For more facts, please consult the following resources:

  • American Cancer Society (ACS) New Cervical Cancer Screening Guidelines
  • Health Resources and Services Administration (HRSA) Endorsement of New Guidelines
  • HPV and Cervical Cancer-Understanding the Connection and How to Prevent Cancer

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Search:

News Directory 3

ByoDirectory is a comprehensive directory of businesses and services across the United States. Find what you need, when you need it.

Quick Links

  • Disclaimer
  • Terms and Conditions
  • About Us
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Editorial Guidelines
  • Privacy Policy

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

Connect With Us

© 2026 News Directory 3. All rights reserved.

Privacy Policy Terms of Service